Unknown

Dataset Information

0

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12?months of tapering anti-rheumatic drugs.


ABSTRACT: OBJECTIVE:To investigate whether calprotectin (S100A8/A9 or MRP8/14), an inflammatory complex released by monocytes, could indicate residual subclinical inflammation in rheumatoid arthritis (RA) patients who are in stable remission on disease-modifying anti-rheumatic drugs (DMARDs) and serve as a marker for disease flare after DMARD tapering. METHODS:We used data from two trials. Patients from the IMPROVED study had early (

SUBMITTER: de Moel EC 

PROVIDER: S-EPMC6894482 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs.

de Moel Emma C EC   Rech Jürgen J   Mahler Michael M   Roth Johannes J   Vogl Thomas T   Schouffoer Anne A   Goekoop Robbert J RJ   Huizinga Tom W J TWJ   Allaart Cornelia F CF   Toes René E M REM   Schett Georg G   van der Woude Diane D  

Arthritis research & therapy 20191205 1


<h4>Objective</h4>To investigate whether calprotectin (S100A8/A9 or MRP8/14), an inflammatory complex released by monocytes, could indicate residual subclinical inflammation in rheumatoid arthritis (RA) patients who are in stable remission on disease-modifying anti-rheumatic drugs (DMARDs) and serve as a marker for disease flare after DMARD tapering.<h4>Methods</h4>We used data from two trials. Patients from the IMPROVED study had early (< 2 years) RA, and when they achieved disease activity sco  ...[more]

Similar Datasets

| S-EPMC4924696 | biostudies-literature
| S-EPMC4393299 | biostudies-literature
| S-EPMC6004386 | biostudies-literature
| S-EPMC5454315 | biostudies-literature
| S-EPMC7122461 | biostudies-literature